Previous close | 2.1300 |
Open | 2.1500 |
Bid | 2.1400 x 400 |
Ask | 2.1700 x 200 |
Day's range | 2.1400 - 2.2100 |
52-week range | 2.1000 - 4.3000 |
Volume | |
Avg. volume | 476,131 |
Market cap | 215.196M |
Beta (5Y monthly) | 1.47 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1500 |
Earnings date | 01 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.75 |
Comprehensive Analysis of Accuray's Latest Earnings and Financial Health
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024.
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, GKOS, SRDX and ARAY are placed ahead of their earnings releases.